No connection

Search Results

Corporate Score 32 Bullish

Boston Scientific Ascends to Top 10 Analyst Picks in S&P 500

Apr 14, 2026 16:05 UTC
BSX
Medium term

Boston Scientific Corp. has moved up to the 10th position in aggregated analyst rankings for S&P 500 components. The company's stock has seen a substantial year-to-date increase of 45.5%.

  • Ranked #10 among S&P 500 components
  • Moved up one spot in analyst preference
  • YTD stock price gain of 45.5%
  • Ranking based on average brokerage opinions

Boston Scientific Corp. (BSX) has seen its standing improve among Wall Street analysts, now ranking as the 10th most favored stock within the S&P 500 index. This movement represents a one-spot climb in the overall rankings. The ranking is determined by averaging the opinions of major brokerage houses for each of the 500 components of the index. The shift reflects a sustained positive outlook from the analyst community regarding the company's operational trajectory and market position. Financial performance has mirrored this analyst optimism. Boston Scientific has demonstrated robust price action throughout the current year, posting a year-to-date gain of 45.5%. While the ranking shift is incremental, the combination of high analyst conviction and strong price momentum suggests continued confidence in the medical device manufacturer's growth prospects within the healthcare sector.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Share this article

Related Articles

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Home
Terminal
AI
Markets
Profile